Evidence map›Paper›PMID 31414152›Full record

ReviewDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2019

[Histiocytosis in the dermatological context of the new classification].

C Lang, J-T Maul, L Krähenbühl, F Dimitriou, R Dummer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Infant with nodular cutaneous lesions on the torso and head].Dermatologie (Heidelberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C LangDermatologische Klinik, Universitätsspital Zürich, Gloriastrasse, 8091, Zürich, Schweiz. Claudia.Lang@usz.ch.
J-T MaulDermatologische Klinik, Universitätsspital Zürich, Gloriastrasse, 8091, Zürich, Schweiz.
L KrähenbühlDermatologische Klinik, Universitätsspital Zürich, Gloriastrasse, 8091, Zürich, Schweiz.
F DimitriouDermatologische Klinik, Universitätsspital Zürich, Gloriastrasse, 8091, Zürich, Schweiz.
R DummerDermatologische Klinik, Universitätsspital Zürich, Gloriastrasse, 8091, Zürich, Schweiz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histiocytoses comprises a heterogeneous group of inflammatory diseases for which dendritic cells and macrophages are the main cellular components. The inflammatory infiltrate can affect the skin and other organs, and clinical outcome varies from mild to lethal depending on the involved cell subset and organ infiltration as well as comorbidities. Until recently, the group of histiocytosis was divided into Langerhans cell histiocytosis, non-Langerhans cell histiocytosis and malignant histiocytosis. With the new classification from JF Emile et al., the subgroups were determined regarding clinical, histiopathological, radiological, phenotype, genetic, and molecular features. In this review, we explain the revised classification with emphasis on dermatological and molecular aspects.

Indexed as

Histiocytosis, Langerhans-CellHistiocytosis, Non-Langerhans-CellHumansErdheim Chester diseaseHistiocytosisLangerhans cell histiocytosisTherapy outcomeXanthogranuloma

Identifiers

PMID31414152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.